Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 9 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

5Total

Not Applicable (2)

P 3 (1)

P 4 (2)

Trial Status

Completed6

Unknown1

Not Yet Recruiting1

Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT03211520CompletedPrimary

Magnetic Resonance Imaging:A Window to Anthracycline Toxicity

NCT06948266Active Not RecruitingPrimary

The Study Aims to Investigate the Frequency and Clinical Characteristics of Out-of-hospital Cardiac Arrests (OHCA) Occurring in Poland in 2023. This Research Seeks to Provide a Comprehensive Analysis of OHCA Incidents Across the Country, Focusing on Their Prevalence and the Associated Clinical fe

NCT06787781Not ApplicableCompleted

Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects

NCT06729086Not ApplicableNot Yet RecruitingPrimary

Propofol vs Sevoflurane in Cardiac Surgery

NCT03211442Completed

Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events

NCT02819739Phase 3CompletedPrimary

Impact of Hyperoxia During Cardiopulmonary

NCT01916733Completed

A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study

NCT00747331Phase 4CompletedPrimary

Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass